BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 27136203)

  • 1. Overrepresentation of IL-10-Expressing B Cells Suppresses Cytotoxic CD4+ T Cell Activity in HBV-Induced Hepatocellular Carcinoma.
    Xue H; Lin F; Tan H; Zhu ZQ; Zhang ZY; Zhao L
    PLoS One; 2016; 11(5):e0154815. PubMed ID: 27136203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients.
    Fu J; Xu D; Liu Z; Shi M; Zhao P; Fu B; Zhang Z; Yang H; Zhang H; Zhou C; Yao J; Jin L; Wang H; Yang Y; Fu YX; Wang FS
    Gastroenterology; 2007 Jun; 132(7):2328-39. PubMed ID: 17570208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blocking Tim-3 or/and PD-1 reverses dysfunction of tumor-infiltrating lymphocytes in HBV-related hepatocellular carcinoma.
    Liu F; Zeng G; Zhou S; He X; Sun N; Zhu X; Hu A
    Bull Cancer; 2018 May; 105(5):493-501. PubMed ID: 29576222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tim-3/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma.
    Li H; Wu K; Tao K; Chen L; Zheng Q; Lu X; Liu J; Shi L; Liu C; Wang G; Zou W
    Hepatology; 2012 Oct; 56(4):1342-51. PubMed ID: 22505239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HBV-specific CD4+ cytotoxic T cells in hepatocellular carcinoma are less cytolytic toward tumor cells and suppress CD8+ T cell-mediated antitumor immunity.
    Meng F; Zhen S; Song B
    APMIS; 2017 Aug; 125(8):743-751. PubMed ID: 28493520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impairment of CD4+ cytotoxic T cells predicts poor survival and high recurrence rates in patients with hepatocellular carcinoma.
    Fu J; Zhang Z; Zhou L; Qi Z; Xing S; Lv J; Shi J; Fu B; Liu Z; Zhang JY; Jin L; Zhao Y; Lau GK; Zhao J; Wang FS
    Hepatology; 2013 Jul; 58(1):139-49. PubMed ID: 22961630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HBV-specific CD8 T cells present higher TNF-α expression but lower cytotoxicity in hepatocellular carcinoma.
    Zhao L; Jin Y; Yang C; Li C
    Clin Exp Immunol; 2020 Sep; 201(3):289-296. PubMed ID: 32474905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXCR5
    Jin Y; Lang C; Tang J; Geng J; Song HK; Sun Z; Wang J
    Int Immunopharmacol; 2017 Dec; 53():42-48. PubMed ID: 29032029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of Tim-3, PD-1, and CCR5 on peripheral T and B lymphocytes in hepatitis C virus-related hepatocellular carcinoma and their impact on treatment outcomes.
    Zahran AM; Hetta HF; Rayan A; Eldin AS; Hassan EA; Fakhry H; Soliman A; El-Badawy O
    Cancer Immunol Immunother; 2020 Jul; 69(7):1253-1263. PubMed ID: 32170378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical impact of herpesvirus entry mediator expression in human hepatocellular carcinoma.
    Hokuto D; Sho M; Yamato I; Yasuda S; Obara S; Nomi T; Nakajima Y
    Eur J Cancer; 2015 Jan; 51(2):157-65. PubMed ID: 25468715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TIM-3 plays a more important role than PD-1 in the functional impairments of cytotoxic T cells of malignant Schwannomas.
    Li Z; Liu X; Guo R; Wang P
    Tumour Biol; 2017 May; 39(5):1010428317698352. PubMed ID: 28475007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tim-3 negatively regulates cytotoxicity in exhausted CD8+ T cells in HIV infection.
    Sakhdari A; Mujib S; Vali B; Yue FY; MacParland S; Clayton K; Jones RB; Liu J; Lee EY; Benko E; Kovacs C; Gommerman J; Kaul R; Ostrowski MA
    PLoS One; 2012; 7(7):e40146. PubMed ID: 22792231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reciprocal granzyme/perforin-mediated death of human regulatory and responder T cells is regulated by interleukin-2 (IL-2).
    Czystowska M; Strauss L; Bergmann C; Szajnik M; Rabinowich H; Whiteside TL
    J Mol Med (Berl); 2010 Jun; 88(6):577-88. PubMed ID: 20225066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of granzyme B and T cell cytotoxic capacity by IL-2 or IL-15 without antigens: multiclonal responses that are extremely lytic if triggered and short-lived after cytokine withdrawal.
    Tamang DL; Redelman D; Alves BN; Vollger L; Bethley C; Hudig D
    Cytokine; 2006 Nov; 36(3-4):148-59. PubMed ID: 17188506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulatory T cells in chronic hepatitis B patients affect the immunopathogenesis of hepatocellular carcinoma by suppressing the anti-tumour immune responses.
    Zhang HH; Mei MH; Fei R; Liu F; Wang JH; Liao WJ; Qin LL; Wei L; Chen HS
    J Viral Hepat; 2010 Mar; 17 Suppl 1():34-43. PubMed ID: 20586932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of Tim-3/Galectin-9 pathway and CD8+T cells and related factors in patients with cystic echinococcosis.
    Zhao H; Ma Y; Tian F; Li B; Xiao N; Mo X; Aibibula M; Min H; Cai X; Zhang T; Ma X
    Exp Parasitol; 2023 Nov; 254():108623. PubMed ID: 37793539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered cytokine levels and increased CD4+CD57+ T cells in the peripheral blood of hepatitis C virus-related hepatocellular carcinoma patients.
    Shiraki T; Takayama E; Magari H; Nakata T; Maekita T; Enomoto S; Mori Y; Shingaki N; Moribata K; Deguchi H; Ueda K; Inoue I; Mizuno-Kamiya M; Yashiro K; Iguchi M; Tamai H; Kameyama Y; Kato J; Kondoh N; Ichinose M
    Oncol Rep; 2011 Jul; 26(1):201-8. PubMed ID: 21491089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumour activity mediated by CD4+ cytotoxic T lymphocytes against MHC class II-negative mouse hepatocellular carcinoma induced by dendritic cell vaccine and interleukin-12.
    Homma S; Komita H; Sagawa Y; Ohno T; Toda G
    Immunology; 2005 Aug; 115(4):451-61. PubMed ID: 16011514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin 10-expressing B cells inhibit tumor-infiltrating T cell function and correlate with T cell Tim-3 expression in renal cell carcinoma.
    Cai C; Zhang J; Li M; Wu ZJ; Song KH; Zhan TW; Wang LH; Sun YH
    Tumour Biol; 2016 Jun; 37(6):8209-18. PubMed ID: 26715281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NKT and CD8 lymphocytes mediate suppression of hepatocellular carcinoma growth via tumor antigen-pulsed dendritic cells.
    Shibolet O; Alper R; Zlotogarov L; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
    Int J Cancer; 2003 Aug; 106(2):236-43. PubMed ID: 12800200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.